Use of ginseng in medicine with emphasis on neurodegenerative disorders

被引:189
作者
Radad, K [1 ]
Gille, G
Liu, LL
Rausch, WD
机构
[1] Assiut Univ, Dept Pathol & Clin Pathol, Fac Vet Med, Assiut, Egypt
[2] Tech Univ Dresden, Dept Neurol, D-01307 Dresden, Germany
[3] Jilin Univ, Changchun 130012, Peoples R China
[4] Vet Med Univ, Inst Med Chem, A-1210 Vienna, Austria
关键词
ginseng; ginsenoside; central nervous system; herbal medicine; Chinese herb;
D O I
10.1254/jphs.CRJ05010X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ginseng, the root of Panax species, is a well-known herbal medicine. It has been used as a traditional medicine in China, Korea, and Japan for thousands of years and is now a popular and worldwide used natural medicine. The active ingredients of ginseng are ginsenosides which are also called ginseng saponins. Recently, there is increasing evidence in the literature on the pharmacological and physiological actions of ginseng. However, ginseng has been used primarily as a tonic to invigorate week bodies and help the restoration of homeostasis. Current in vivo and in vitro studies have shown its beneficial effects in a wide range of pathological conditions such as cardiovascular diseases, cancer, immune deficiency, and hepatotoxicity. Moreover, recent research has suggested that some of ginseng's active ingredients also exert beneficial effects on aging, central nervous system (CNS) disorders, and neurodegenerative diseases. In general, antioxidant, anti-inflammatory, anti-apoptotic, and immune-stimulatory activities are mostly underlying the possible ginseng-mediated protective mechanisms. Next to animal studies, data from neural cell Cultures contribute to the understanding of these mechanisms that involve decreasing nitric oxide (NO), scavenging of free radicals, and counteracting excitotoxicity. In this review, we focus on recently reported medicinal effects of ginseng and summarize the current knowledge of its effects on CNS disorders and neurodegenerative diseases.
引用
收藏
页码:175 / 186
页数:12
相关论文
共 155 条
[1]  
AHN Y K, 1987, Yakhak Hoeji, V31, P355
[2]   Ginseng pharmacology - Multiple constituents and multiple actions [J].
Attele, AS ;
Wu, JA ;
Yuan, CS .
BIOCHEMICAL PHARMACOLOGY, 1999, 58 (11) :1685-1693
[3]   Ginsenoside Rh-4, a genuine dammarane glycoside from Korean red ginseng [J].
Baek, NI ;
Kim, DS ;
Lee, YH ;
Park, JD ;
Lee, CB ;
Kim, SI .
PLANTA MEDICA, 1996, 62 (01) :86-87
[4]   EVALUATION OF THE ERGOGENIC PROPERTIES OF GINSENG [J].
BAHRKE, MS ;
MORGAN, WP .
SPORTS MEDICINE, 1994, 18 (04) :229-248
[5]   ACTIONS OF GINSENOSIDE-RB1 ON CHOLINE UPTAKE IN CENTRAL CHOLINERGIC NERVE-ENDINGS [J].
BENISHIN, CG .
NEUROCHEMISTRY INTERNATIONAL, 1992, 21 (01) :1-5
[6]  
BLUMENTHAL M, 2001, ADV NURSE PRACT, V2, P26
[7]  
BRAUGHLER JM, 1988, J PHARMACOL EXP THER, V244, P423
[8]   NEW SUBSTANCES OF PLANT ORIGIN WHICH INCREASE NONSPECIFIC RESISTANCE [J].
BREKHMAN, II ;
DARDYMOV, IV .
ANNUAL REVIEW OF PHARMACOLOGY, 1969, 9 :419-&
[9]   Modulation of protein kinase C activity in NIH 313 cells by plant glycosides from Panax ginseng [J].
Byun, BH ;
Shin, I ;
Yoon, YS ;
Kim, SI ;
Joe, CO .
PLANTA MEDICA, 1997, 63 (05) :389-392
[10]  
Chang MS, 1999, PHYTOTHER RES, V13, P641, DOI 10.1002/(SICI)1099-1573(199912)13:8&lt